Mid-Essex Skin Cancer Service Ltd 12972666 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is Skin cancer services Digita Accounts Production Advanced 6.30.9574.0 true 12972666 2023-04-01 2024-03-31 12972666 2024-03-31 12972666 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 12972666 bus:Micro-entities 2023-04-01 2024-03-31 12972666 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 12972666 bus:FullAccounts 2023-04-01 2024-03-31 12972666 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 12972666 bus:RegisteredOffice 2023-04-01 2024-03-31 12972666 bus:Director1 2023-04-01 2024-03-31 12972666 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 12972666 countries:EnglandWales 2023-04-01 2024-03-31 12972666 2022-04-01 2023-03-31 12972666 2023-03-31 12972666 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 iso4217:GBP xbrli:pure

Registration number: 12972666

Mid-Essex Skin Cancer Service Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2024

 

Mid-Essex Skin Cancer Service Ltd

(Registration number: 12972666)
Balance Sheet as at 31 March 2024

2024
£

2023
£

Fixed assets

2,758

226

Current assets

112,893

91,837

Creditors: Amounts falling due within one year

(14,852)

(31,671)

Net current assets

98,041

60,166

Total assets less current liabilities

100,799

60,392

Accruals and deferred income

(2,653)

(1,453)

 

98,146

58,939

Capital and reserves

98,146

58,939

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
6 Maple House
Woodlands Way
Chelmsford
CM1 7TN

These financial statements were authorised for issue by the director on 2 January 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 2 (2023 - 2).

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved and authorised by the director on 2 January 2024
 

 

Mid-Essex Skin Cancer Service Ltd

(Registration number: 12972666)
Balance Sheet as at 31 March 2024

.........................................
Mr N. El-Muttardi
Director